Checkpoint kinase 1 (Chk1) plays a pivotal role in cellular response to DNA damage and replication stress, functioning as a key mediator of cell cycle checkpoints and DNA repair mechanisms. Its primary function is to ensure genomic integrity by halting cell cycle progression in response to DNA damage or incomplete replication, thereby preventing the transmission of genetic abnormalities to daughter cells. Chk1 operates primarily in the S and G2 phases of the cell cycle, where it phosphorylates and regulates a network of downstream targets involved in cell cycle arrest, DNA repair, and apoptosis.
Activation of Chk1 typically occurs in response to various forms of genotoxic stress, such as DNA damage induced by ionizing radiation, or UV light,. Upon detection of DNA damage, upstream signaling pathways, including the ataxia-telangiectasia mutated (ATM) and ataxia-telangiectasia and Rad3-related (ATR) kinases, are activated. These kinases phosphorylate and activate Chk1 by inducing its autophosphorylation at serine 296 and subsequent phosphorylation at serine 317 and serine 345. Activated Chk1 then phosphorylates downstream effectors, such as Cdc25 phosphatases, which leads to their sequestration in the cytoplasm and prevents their function in activating cyclin-dependent kinases (Cdks). Consequently, cell cycle progression is halted, allowing time for DNA repair processes to occur before cell division proceeds. Additionally, activated Chk1 can also promote DNA repair through direct phosphorylation of proteins involved in homologous recombination and nucleotide excision repair pathways, further contributing to genomic stability.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Causes DNA damage that triggers ATR kinase, leading to Chk1 phosphorylation and activation. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Inhibits ribonucleotide reductase causing replication stress, which can lead to Chk1 activation. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Causes DNA breaks that signal through ATR to activate Chk1. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits topoisomerase I, causing DNA breaks and subsequent Chk1 activation. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $112.00 $394.00 | 8 | |
Causes DNA damage that can activate Chk1 through the ATR pathway. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Causes thymidine depletion, leading to replication stress that activates Chk1. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Causes DNA breaks, which lead to Chk1 activation via ATR. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Causes DNA chain termination, leading to replication stress and Chk1 activation. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Inhibits DNA polymerase, causing replication stress and subsequent Chk1 activation. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Intercalates DNA and inhibits topoisomerase II, causing DNA damage that can lead to Chk1 activation. | ||||||